Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Yi

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
Emerging Microbes & Infections|March 8, 2022
Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variantsHanjun Zhao, Xinjie Meng, Zheng Peng, et al.
Ebiomedicine|September 5, 2025
A strategy to re-sensitise drug-resistant Gram-positive bacteria to oxazolidinone-class antibioticsQi Zhang, Yang Yang, Ying Yang, et al.
Viruses|January 19, 2019
Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling upon Coronavirus ReplicationBingpeng Yan, Hin Chu, Dong Yang, et al.
The Journal of Infectious Diseases|June 22, 2017
Immunotherapy Targeting Adenosine Synthase A Decreases Severity of Staphylococcus aureus Infection in Mouse ModelBao-Zhong Zhang, JianPiao Cai, Bin Yu, et al.
Acta Pharmaceutica Sinica. B|October 6, 2025
Yeast-two-hybrid based high-throughput screening to discover SARS-CoV-2 fusion inhibitors by targeting the HR1/HR2 interactionJing Zhang, Dongsheng Li, Wenwen Zhou, et al.
Antibiotics (Basel, Switzerland)|June 24, 2022
Antivirulence Agent as an Adjuvant of β-Lactam Antibiotics in Treating Staphylococcal InfectionsPeng Gao, Yuanxin Wei, Sherlock Shing Chiu Tai, et al.
Journal of Medicinal Chemistry|February 26, 2020
Methylation of Daptomycin Leading to the Discovery of Kynomycin, a Cyclic Lipodepsipeptide Active against Resistant PathogensHoi Yee Chow, Kathy Hiu Laam Po, Peng Gao, et al.
Journal of Vitreoretinal Diseases|May 1, 2026
A Single-Center Analysis of Variables Used to Select a Vitreoretinal Surgery Training ProgramTimothy M Boyce, Kyle M Green, Ian C Han, et al.
Emerging Microbes & Infections|September 6, 2023
SaeR as a novel target for antivirulence therapy against <i>Staphylococcus aureus</i>Peng Gao, Yuanxin Wei, Suying Hou, et al.
Infection and Immunity|November 5, 2014
Recombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine modelBao Zhong Zhang, Yan Hong Hua, Bin Yu, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
Emerging Microbes & Infections|March 8, 2022
Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variantsHanjun Zhao, Xinjie Meng, Zheng Peng, et al.
Ebiomedicine|September 5, 2025
A strategy to re-sensitise drug-resistant Gram-positive bacteria to oxazolidinone-class antibioticsQi Zhang, Yang Yang, Ying Yang, et al.
Viruses|January 19, 2019
Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling upon Coronavirus ReplicationBingpeng Yan, Hin Chu, Dong Yang, et al.
The Journal of Infectious Diseases|June 22, 2017
Immunotherapy Targeting Adenosine Synthase A Decreases Severity of Staphylococcus aureus Infection in Mouse ModelBao-Zhong Zhang, JianPiao Cai, Bin Yu, et al.
Acta Pharmaceutica Sinica. B|October 6, 2025
Yeast-two-hybrid based high-throughput screening to discover SARS-CoV-2 fusion inhibitors by targeting the HR1/HR2 interactionJing Zhang, Dongsheng Li, Wenwen Zhou, et al.
Antibiotics (Basel, Switzerland)|June 24, 2022
Antivirulence Agent as an Adjuvant of β-Lactam Antibiotics in Treating Staphylococcal InfectionsPeng Gao, Yuanxin Wei, Sherlock Shing Chiu Tai, et al.
Journal of Medicinal Chemistry|February 26, 2020
Methylation of Daptomycin Leading to the Discovery of Kynomycin, a Cyclic Lipodepsipeptide Active against Resistant PathogensHoi Yee Chow, Kathy Hiu Laam Po, Peng Gao, et al.
Journal of Vitreoretinal Diseases|May 1, 2026
A Single-Center Analysis of Variables Used to Select a Vitreoretinal Surgery Training ProgramTimothy M Boyce, Kyle M Green, Ian C Han, et al.
Emerging Microbes & Infections|September 6, 2023
SaeR as a novel target for antivirulence therapy against <i>Staphylococcus aureus</i>Peng Gao, Yuanxin Wei, Suying Hou, et al.
Infection and Immunity|November 5, 2014
Recombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine modelBao Zhong Zhang, Yan Hong Hua, Bin Yu, et al.
Pageof 14